Thai patient-derived CCA cell lines, KKU-055 (JCRB1551) [34], KKU-100 (JCRB1568) [36], KKU-213 (previously known as KKU-M213) (JCRB1557) [41] and HuCCA-1 (JCRB1657) [35], as well as immortalized cholangiocyte cell line MMNK-1 (JCRB1554) [42] from the Japanese Collection of Research Cell Bank (JCRB) were maintained in a humidified 5% CO2 incubator at 37°C in HAM’s F-12 media (GIBCO, Grand Island, NY, USA) containing 15 mM HEPES, 14 mM NaHCO3, 100 U/ml penicillin G (GIBCO), 100 U/ml streptomycin (GIBCO), and 10% heat-inactivated fetal bovine serum (FBS) (GIBCO). KKU-055 and KKU-100 were developed from patients with poorly differentiated adenocarcinoma and the latter appears to be multidrug resistant cell lines [34]. Basal proliferation, migration and invasion abilities of HuCCA-1 were relatively low when compared to that of KKU-213 [21,35,43].
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
 Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.